ACXP - Acurx Pharmaceuticals, Inc. (ACXP) Q4 2024 Earnings Call Transcript
2025-03-18 09:44:50 ET
Acurx Pharmaceuticals, Inc. (ACXP)
Q4 2024 Earnings Conference Call
March 18, 2025, 8:00 AM ET
Company Participants
Robert Shawah - Co-Founder and Chief Financial Officer
David Luci - President and Chief Executive Officer
Conference Call Participants
Thomas Yip - H.C. Wainwright
James Molloy - Alliance Global Partners
Claire Acheson - Independent Investment Research
Presentation
Operator
Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter and Full Year 2024 Financial Results and Business Update. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
I'll now turn the conference over to your host Mr. Robert Shawah, Chief Financial Officer for Acurx Pharmaceuticals. Please go ahead, sir.
Robert Shawah
Thank you, Melissa. Good morning and welcome to our call. This morning, we issued a press release providing financial results and company highlights for the fourth quarter and full year 2024, which is available on our website at acurxpharma.com....
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2024 Earnings Call Transcript